Literature DB >> 26593292

Cancer Risk and Surveillance in Primary Sclerosing Cholangitis.

Trine Folseraas1, Kirsten Muri Boberg2.   

Abstract

Primary sclerosing cholangitis (PSC) is a chronic, progressive disease characterized by inflammatory and fibrosing strictures of the biliary tree. PSC is associated with a high lifetime risk of hepatobiliary and colorectal cancers. The nature of the carcinogenic process in PSC is not well established. The lack of diagnostic methods for early detection and the limited therapeutic options for cholangiocarcinoma constitute a major challenge in the current handling of PSC patients. The article reviews the risk for cancer development in PSC and discusses surveillance strategies for PSC-associated cancers.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brush cytology; Carcinoma; Cholangiocarcinoma; Dysplasia; Inflammatory bowel disease; Primary sclerosing cholangitis; Surveillance

Mesh:

Substances:

Year:  2015        PMID: 26593292     DOI: 10.1016/j.cld.2015.08.014

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  12 in total

Review 1.  Adult bile duct strictures: differentiating benign biliary stenosis from cholangiocarcinoma.

Authors:  Hiep Nguyen Canh; Kenichi Harada
Journal:  Med Mol Morphol       Date:  2016-06-27       Impact factor: 2.309

Review 2.  Genetics of primary sclerosing cholangitis and pathophysiological implications.

Authors:  Xiaojun Jiang; Tom H Karlsen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-03-15       Impact factor: 46.802

3.  Blockade of BAFF Reshapes the Hepatic B Cell Receptor Repertoire and Attenuates Autoantibody Production in Cholestatic Liver Disease.

Authors:  Manoj Thapa; Dana Tedesco; Sanjeev Gumber; Elizabeth J Elrod; Jin-Hwan Han; William H Kitchens; Joseph F Magliocca; Andrew B Adams; Arash Grakoui
Journal:  J Immunol       Date:  2020-04-24       Impact factor: 5.422

4.  Primary Sclerosing Cholangitis, Part 2: Cancer Risk, Prevention, and Surveillance.

Authors:  James H Tabibian; Ahmad H Ali; Keith D Lindor
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-07

5.  The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel disease.

Authors:  J Torres; C Palmela; H Brito; X Bao; H Ruiqi; P Moura-Santos; J Pereira da Silva; A Oliveira; C Vieira; K Perez; S H Itzkowitz; J F Colombel; L Humbert; D Rainteau; M Cravo; C M Rodrigues; J Hu
Journal:  United European Gastroenterol J       Date:  2017-05-05       Impact factor: 4.623

6.  Neutralization of IL-15 abrogates experimental immune-mediated cholangitis in diet-induced obese mice.

Authors:  José L Reyes; Danielle T Vannan; Tina Vo; Aliya Gulamhusein; Paul L Beck; Raylene A Reimer; Bertus Eksteen
Journal:  Sci Rep       Date:  2018-02-15       Impact factor: 4.379

7.  Clinical Features and Outcomes of Primary Sclerosing Cholangitis in the Highly Admixed Brazilian Population.

Authors:  Mateus Jorge Nardelli; Paulo Lisboa Bittencourt; Guilherme Grossi Lopes Cançado; Luciana Costa Faria; Cristiane Alves Villela-Nogueira; Vivian Rotman; Eliabe Silva de Abreu; Fernanda Maria Farage Osório; Andreia Silva Evangelista; Liliana Sampaio Costa Mendes; Daniel Ferraz de Campos Mazo; Elodie Bonfim Hyppolito; Adrielly de Souza Martins; Liana Codes; Izabelle Venturini Signorelli; Geisa Perez Medina Gomide; Luciana Agoglia; Claudia Alexandra Pontes Ivantes; Valéria Ferreira de Almeida E Borges; Gabriela Perdomo Coral; Rosamar Eulira Fontes Rezende; Maria Lucia Gomes Ferraz; Debora Raquel Benedita Terrabuio; Eduardo Luiz Rachid Cançado; Claudia Alves Couto
Journal:  Can J Gastroenterol Hepatol       Date:  2021-11-10

8.  Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland.

Authors:  Nina Barner-Rasmussen; Eero Pukkala; Kishor Hadkhale; Martti Färkkilä
Journal:  United European Gastroenterol J       Date:  2021-09-17       Impact factor: 4.623

9.  Association of young age and male sex with primary sclerosing cholangitis in Taiwanese patients with inflammatory bowel disease.

Authors:  Meng-Tzu Weng; I-Lun Shih; Chien-Chih Tung; Yew-Loong Leong; Ming-Jium Shieh; Cheng-Yi Wang; Jau-Min Wong; Yen-Hsuan Ni; Shu-Chen Wei
Journal:  Intest Res       Date:  2022-02-08

10.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei in a liver-transplanted patient: a case report.

Authors:  Ebbe Billmann Thorgersen; Espen Melum; Trine Folseraas; Stein Gunnar Larsen; Pål Dag Line
Journal:  World J Surg Oncol       Date:  2018-09-05       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.